Wondfo Biotech (300482.SZ) released its performance for the first three quarters, with net profit attributable to shareholders of RMB 134 million, flat year-on-year.

Zhitong Finance APP News, Wondfo Biotech (300482.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 1.569 billion yuan, a year-on-year decrease of 7.18%. Net profit attributable to shareholders of the listed company was 134 million yuan, a year-on-year increase of 0.10%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 85.8545 million yuan, a year-on-year increase of 3.89%.